In cell lines of esophageal [7]–[9] and colo-rectal cancer [11] and glioma [8], the overexpression of ECRG4 inhibits cell proliferation by blocking the G1/S transition of cell cycle, through increase of p21 and p53 protein expression. This evidence concerns the gene TP53 and central nervous system cancer.